M, P., B, C., C, A., A, C., MG, C., V, C., & MC, G. (2021). Imaging post-177Lu-peptide receptor radionuclide therapy in a child with advanced progressive somatostatin-receptor-positive medulloblastoma. European journal of nuclear medicine and molecular imaging, 48(3), 937. https://doi.org/10.1007/s00259-020-04966-w
Chicago Style (17th ed.) CitationM, Pizzoferro, Cassano B, Altini C, Cacchione A, Cefalo MG, Cannatà V, and Garganese MC. "Imaging Post-177Lu-peptide Receptor Radionuclide Therapy in a Child with Advanced Progressive Somatostatin-receptor-positive Medulloblastoma." European Journal of Nuclear Medicine and Molecular Imaging 48, no. 3 (2021): 937. https://doi.org/10.1007/s00259-020-04966-w.
MLA (9th ed.) CitationM, Pizzoferro, et al. "Imaging Post-177Lu-peptide Receptor Radionuclide Therapy in a Child with Advanced Progressive Somatostatin-receptor-positive Medulloblastoma." European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, no. 3, 2021, p. 937, https://doi.org/10.1007/s00259-020-04966-w.